Acadian Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,186
| Closed | -$22K | – | 2075 |
|
|
2021
Q2 | $22K | Sell |
2,186
-3,693
| -63% | -$37.2K | ﹤0.01% | 1934 |
|
|
2021
Q1 | $69K | Buy |
5,879
+2,315
| +65% | +$27.2K | ﹤0.01% | 1759 |
|
|
2020
Q4 | $127K | Sell |
3,564
-1,597
| -31% | -$56.9K | ﹤0.01% | 1683 |
|
|
2020
Q3 | $71K | Sell |
5,161
-30,884
| -86% | -$425K | ﹤0.01% | 1762 |
|
|
2020
Q2 | $594K | Buy |
+36,045
| New | +$594K | ﹤0.01% | 1140 |
|
|
2020
Q1 | – | Sell |
-57,069
| Closed | -$1.3M | – | 1964 |
|
|
2019
Q4 | $1.3M | Sell |
57,069
-5,084
| -8% | -$116K | 0.01% | 813 |
|
|
2019
Q3 | $889K | Buy |
62,153
+1,454
| +2% | +$20.8K | ﹤0.01% | 922 |
|
|
2019
Q2 | $808K | Buy |
60,699
+15,801
| +35% | +$210K | ﹤0.01% | 859 |
|
|
2019
Q1 | $780K | Buy |
44,898
+9,175
| +26% | +$159K | ﹤0.01% | 978 |
|
|
2018
Q4 | $489K | Buy |
35,723
+3,602
| +11% | +$49.3K | ﹤0.01% | 909 |
|
|
2018
Q3 | $691K | Buy |
32,121
+3,403
| +12% | +$73.2K | ﹤0.01% | 812 |
|
|
2018
Q2 | $1.23M | Buy |
+28,718
| New | +$1.23M | 0.01% | 683 |
|
|
2018
Q1 | – | Sell |
-2,163
| Closed | -$158K | – | 1869 |
|
|
2017
Q4 | $158K | Buy |
2,163
+1,530
| +242% | +$112K | ﹤0.01% | 1001 |
|
|
2017
Q3 | $58K | Buy |
+633
| New | +$58K | ﹤0.01% | 1088 |
|
|
2017
Q1 | – | Sell |
-2,705
| Closed | -$250K | – | 1811 |
|
|
2016
Q4 | $250K | Buy |
+2,705
| New | +$250K | ﹤0.01% | 978 |
|
|
2016
Q2 | – | Sell |
-73,042
| Closed | -$12M | – | 1555 |
|
|
2016
Q1 | $12M | Sell |
73,042
-17,486
| -19% | -$2.86M | 0.06% | 254 |
|
|
2015
Q4 | $29.6M | Buy |
90,528
+28,313
| +46% | +$9.27M | 0.15% | 163 |
|
|
2015
Q3 | $20.1M | Buy |
62,215
+18,814
| +43% | +$6.07M | 0.11% | 194 |
|
|
2015
Q2 | $17.3M | Buy |
+43,401
| New | +$17.3M | 0.08% | 212 |
|